Advanced search
Publication Cover
Leukemia & Lymphoma Volume 26, 1997 - Issue 3-4
Submit an article Journal homepage
32
Views
43
CrossRef citations to date
0
Altmetric
Original Article

Nodular Lymphocyte Predominance Hodgkin's Disease: Long-Term Observation Reveals a Continuous Pattern of Recurrence

Ester Orlandi Division of Hematology, IRCCS Policlinico S. Matteo, Piazzale Golgi 2, Pavia, and Institute of Hematology, Pavia, Italy
,
Mario Lazzarino Division of Hematology, IRCCS Policlinico S. Matteo, Piazzale Golgi 2, Pavia, and Institute of Hematology, Pavia, Italy
,
Ercole Brusamolino Division of Hematology, IRCCS Policlinico S. Matteo, Piazzale Golgi 2, Pavia, and Institute of Hematology, Pavia, Italy
,
Marco Paulli Department of Pathology and Research Unit, University of Pavia, Pavia, Italy
,
Cesare Astori Division of Hematology, IRCCS Policlinico S. Matteo, Piazzale Golgi 2, Pavia, and Institute of Hematology, Pavia, Italy
,
Umberto Magrini Department of Pathology and Research Unit, University of Pavia, Pavia, Italy
&
Carlo Bernasconi Division of Hematology, IRCCS Policlinico S. Matteo, Piazzale Golgi 2, Pavia, and Institute of Hematology, Pavia, Italy
 show all
Pages 359-368 | Published online: 01 Jul 2009

Citations (43)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Zachary H Word & Matthew J Matasar. (2012) Advances in the diagnosis and management of lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 2, pages 29-55.
Read now
Eliza A. Hawkes, Andrew Wotherspoon & David Cunningham. (2012) The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management. Leukemia & Lymphoma 53:3, pages 354-361.
Read now
Katrina Farrell, Pamela Mckay & Mike Leach. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network. Leukemia & Lymphoma 52:10, pages 1920-1928.
Read now

Articles from other publishers (40)

Manuel Gotti, Roberta Sciarra, Alessandro Pulsoni, Francesco Merli, Stefano Luminari, Caterina Zerbi, Livio Trentin, Alessandro Re, Chiara Rusconi, Simonetta Viviani, Andrea Rossi, Federica Cocito, Barbara Botto, Erika Meli, Antonello Pinto, Irene Dogliotti, Guido Gini, Benedetta Puccini, Francesca Ricci, Luca Nassi, Alberto Fabbri, Anna Marina Liberati, Michele Merli, Andrea Riccardo Filippi, Maurizio Bonfichi, Valentina Zoboli, Germana Tartaglia, Giorgia Annechini, Gianna Maria D’Elia, Ilaria Del Giudice, Isabel Alvarez, Andrea Visentin, Stefano Pravato, Daniela Dalceggio, Chiara Pagani, Silvia Ferrari, Caterina Cristinelli, Tanja Lazic, Virginia Valeria Ferretti, Umberto Ricardi & Luca Arcaini. (2023) Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. HemaSphere 7:4, pages e837.
Crossref
Justin Budnik, Christopher Doucette, Michael T. Milano & Louis S. Constine. (2020) Survival of Patients With Second Primary Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia 20:5, pages 316-323.e2.
Crossref
Sven BorchmannErel Joffe, Craig H. MoskowitzAndrew D. Zelenetz, Ariela Noy, Carol S. PortlockJohn F. Gerecitano, Connie L. Batlevi, Philip C. CaronPamela Drullinsky, Audrey HamiltonPaul A. HamlinJrJr, Steven M. Horwitz, Anita KumarMatthew J. Matasar, Alison J. Moskowitz, Colette N. Owens, M. Lia Palomba, Anas Younes & David J. Straus. (2019) Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood 133:20, pages 2121-2129.
Crossref
Bismarck Odei, Dustin Boothe, Jonathan Frandsen, Matthew M. Poppe & David K. Gaffney. (2017) The Role of Radiation in All Stages of Nodular Lymphocytic Predominant Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia 17:12, pages 819-824.
Crossref
Andrew G. Evans & Paul M. Barr. 2017. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer 760 775 .
Kerry J. Savage, Anja Mottok & Michelle Fanale. (2016) Nodular lymphocyte-predominant Hodgkin lymphoma. Seminars in Hematology 53:3, pages 190-202.
Crossref
Toby A. Eyre, Kevin Gatter, Graham P. Collins, Georgina W. Hall, Caroline Watson & Chris S.R. Hatton. (2015) Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant hodgkin lymphoma: Long-term outcomes from a 30-year experience. American Journal of Hematology 90:6, pages E103-E110.
Crossref
Karen L. Chang, Daniel A. Arber & Lawrence M. Weiss. 2015. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 688 812 .
Jean Fran?ois Grellier, Laetitia Vercellino, Thierry Leblanc, Pascal Merlet, Catherine Thieblemont, Pierre Weinmann, Marie-Elisabeth Toubert, Nathalie Berenger, Josette Bri?re & Pauline Brice. (2014) Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 41:11, pages 2023-2030.
Crossref
Katharine H. XingJoseph M. ConnorsAnky LaiMubarak Al-Mansour, Laurie H. SehnDiego VillaRichard KlasaTamara ShenkierRandy D. Gascoyne, Brian Skinnider & Kerry J. Savage. (2014) Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis. Blood 123:23, pages 3567-3573.
Crossref
Marguerite Tyran, Laurence Gonzague, Reda Bouabdallah & Michel Resbeut. (2014) Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma. Case Reports in Hematology 2014, pages 1-5.
Crossref
Katharine H. Xing & Kerry J. Savage. (2013) Modern management of lymphocyte predominant Hodgkin lymphoma. British Journal of Haematology 161:3, pages 316-329.
Crossref
Burton E. Appel, Lu Chen, Allen Buxton, Suzanne L. Wolden, David C. Hodgson & James B. Nachman. (2012) Impact of low‐dose involved‐field radiation therapy on pediatric patients with lymphocyte‐predominant Hodgkin lymphoma treated with chemotherapy: A report from the Children's Oncology Group. Pediatric Blood & Cancer 59:7, pages 1284-1289.
Crossref
Paul M. Barr & Jonathan W. Friedberg. 2012. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer 617 626 .
Ronald C. Chen & Peter M. Mauch. 2011. Radiotherapy for Hodgkin Lymphoma. Radiotherapy for Hodgkin Lymphoma 53 66 .
Lale Kostakoglu. 2011. Clinical PET-CT in Radiology. Clinical PET-CT in Radiology 265 291 .
Mubarak Al-MansourJoseph M. ConnorsRandy D. GascoyneBrian SkinniderKerry J. Savage. (2010) Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma. Journal of Clinical Oncology 28:5, pages 793-799.
Crossref
Irene Biasoli, Aspasia Stamatoullas, Véronique Meignin, Alain Delmer, Oumedaly Reman, Franck Morschhauser, Bertrand Coiffier, André Bosly, Marine Diviné & Pauline Brice. (2009) Nodular, lymphocyte‐predominant Hodgkin lymphoma. Cancer 116:3, pages 631-639.
Crossref
Ronald C. ChenMichael S. ChinAndrea K. NgYang FengDonna NeubergBarbara SilverGeraldine S. PinkusMary Ann StevensonPeter M. Mauch. (2010) Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up. Journal of Clinical Oncology 28:1, pages 136-141.
Crossref
Bertram Schnitzer. (2009) Hodgkin Lymphoma. Hematology/Oncology Clinics of North America 23:4, pages 747-768.
Crossref
Alfred Ian Lee & Ann S. LaCasce. (2009) Nodular Lymphocyte Predominant Hodgkin Lymphoma. The Oncologist 14:7, pages 739-751.
Crossref
Rick L.M. Haas, Theo Girinsky, Berthe M.P. Aleman, Michel Henry-Amar, Jan-Paul de Boer & Daphne de Jong. (2009) Low-Dose Involved-Field Radiotherapy as Alternative Treatment of Nodular Lymphocyte Predominance Hodgkin's Lymphoma. International Journal of Radiation Oncology*Biology*Physics 74:4, pages 1199-1202.
Crossref
KAREN L. CHANG, DANIEL A. ARBER & LAWRENCE M. WEISS. 2009. Modern Surgical Pathology. Modern Surgical Pathology 1431 1511 .
Matthew J. Matasar & Andrew D. Zelenetz. (2008) Overview of Lymphoma Diagnosis and Management. Radiologic Clinics of North America 46:2, pages 175-198.
Crossref
G. W. Hall, N. Katzilakis, C. R. Pinkerton, G. Nicolin, S. Ashley, Keith McCarthy, S. Daw, M. Hewitt, W. H. Wallace & A. Shankar. (2007) Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report. British Journal of Haematology 138:6, pages 761-768.
Crossref
Henry K. Tsai & Peter M. Mauch. (2007) Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Seminars in Radiation Oncology 17:3, pages 184-189.
Crossref
Lucia Nogová, Thomas Rudiger & Andreas Engert. (2006) Biology, Clinical Course and Management of Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Hematology 2006:1, pages 266-272.
Crossref
Andrew Wirth, Kally Yuen, Michael Barton, Daniel Roos, Kumar Gogna, Gary Pratt, Craig MacLeod, Sean Bydder, Graeme Morgan & David Christie. (2005) Long‐term outcome after radiotherapy alone for lymphocyte‐predominant Hodgkin lymphoma. Cancer 104:6, pages 1221-1229.
Crossref
Bertram Schnitzer & Riccardo Valdez. 2004. Hematopathology in Oncology. Hematopathology in Oncology 259 290 .
Valerie K. Ibom, Robert M. Prosnitz, Jerald Z. Gong, Joseph O. Moore, Carlos M. DeCastro, Leonard R. Prosnitz, David A. Rizzieri & Jon P. Gockerman. (2003) Rituximab in Lymphocyte Predominance Hodgkin's Disease: A Case Series. Clinical Lymphoma 4:2, pages 115-118.
Crossref
B. PellegrinoM.J. Terrier-LacombeO. OberlinT. LeblancY. PerelY. BertrandC. BeardC. EdanC. SchmittD. PlantazH. PacquementJ.P. VannierC. LambillioteG. CouillaultA. Babin-BoilletotI. ThuretF. DemeocqG. LevergerG. DelsolJ. Landman-Parker. (2003) Lymphocyte-Predominant Hodgkin’s Lymphoma in Children: Therapeutic Abstention After Initial Lymph Node Resection—A Study of the French Society of Pediatric Oncology. Journal of Clinical Oncology 21:15, pages 2948-2952.
Crossref
Bradley C. Ekstrand & Sandra J. Horning. (2002) Lymphocyte predominant Hodgkin’s disease. Current Oncology Reports 4:5, pages 424-433.
Crossref
Pamela J. Schlembach, Richard B. Wilder, Dan Jones, Chul S. Ha, Luis E. Fayad, Anas Younes, Fredrick Hagemeister, Mark Hess, Fernando Cabanillas & James D. Cox. (2002) Radiotherapy Alone for Lymphocyte-Predominant Hodgkin??s Disease. The Cancer Journal 8:5, pages 377-383.
Crossref
Richard B. Wilder, Pamela J. Schlembach, Dan Jones, Gregory M. Chronowski, Chul S. Ha, Anas Younes, Fredrick B. Hagemeister, Ibrahim Barista, Fernando Cabanillas & James D. Cox. (2002) European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease. Cancer 94:6, pages 1731-1738.
Crossref
Joseph M. Connors, Evert M. Noordijk & Sandra J. Horning. (2001) Hodgkin's Lymphoma: Basing the Treatment on the Evidence. Hematology 2001:1, pages 178-193.
Crossref
John Elgin, Gregory Phillips, Vishnu V.B. Reddy, Patty O. Gibbs & Catherine M. Listinsky. (1999) Hodgkin's and non-Hodgkin's lymphoma: Spectrum of morphologic and immunophenotypic overlap. Annals of Diagnostic Pathology 3:5, pages 263-275.
Crossref
Volker DiehlMichael SextroJeremy FranklinMartin-Leo HansmannNancy HarrisElaine JaffeSibr PoppemaMartin HarrisKaarle FranssilaJan van KriekenTheresa MarafiotiIoannis AnagnostopoulosHarald Stein. (1999) Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. Journal of Clinical Oncology 17:3, pages 776-776.
Crossref
Jon C. Aster. (1999) Lymphocyte-Predominant Hodgkin's Disease: How Little Therapy Is Enough?. Journal of Clinical Oncology 17:3, pages 744-744.
Crossref
Mary Callaghan. (1998) Hodgkin's disease. Seminars in Oncology Nursing 14:4, pages 262-272.
Crossref
J. Franklin, H. Tesch, M.-L. Hansmann & V. Diehl. (1998) Lymphocyte predominant Hodgkin’s disease: Pathology and clinical implication. Annals of Oncology 9, pages s39-s44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.